🇺🇸 FDA
Patent

US 11192885

1-heterocyclyl isochromanyl compounds and analogs for treating CNS disorders

granted A61PA61P25/00A61P25/18

Quick answer

US patent 11192885 (1-heterocyclyl isochromanyl compounds and analogs for treating CNS disorders) held by PGI Drug Discovery LLC expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PGI Drug Discovery LLC
Grant date
Tue Dec 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61P, A61P25/00, A61P25/18, A61P25/22, A61P25/24